Neuropharmacology in the elderly

Neurologic Clinics

Volumn 16, Issue 3, 1998, Pages 599-610

  Kompoliti, K ^a   Goetz, C ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMOXAPINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DESIPRAMINE; DIAZEPAM; FLURAZEPAM; GABAPENTIN; LAMOTRIGINE; LEVODOPA; LORAZEPAM; NEUROLEPTIC AGENT; NORTRIPTYLINE; OXAZEPAM; PHENOBARBITAL; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TEMAZEPAM; TRIAZOLAM; VALPROIC ACID; VIGABATRIN;

AGED; ANTICHOLINERGIC EFFECT; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; DRUG INDUCED DISEASE; EPILEPSY; HUMAN; INSOMNIA; MENTAL DISEASE; NEUROLOGIC DISEASE; PARKINSON DISEASE; PATIENT COMPLIANCE; POLYPHARMACY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TARDIVE DYSKINESIA;

EID: 0031708485     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(05)70083-9     Document Type: Article

References (32)

1. B. Bach J.M. Hansen J.P. Kampmann Disposition of antipyrine and phenytoin correlated with age and liver volume in man Clin Pharmacokinet 6 1981 389 396
2. R.J. Baldessarini Drugs and the treatment of psychiatric disorders Hardman J.G. Limbird L.E. Goodman & Gilman's: The Pharmacological Basis of Therapeutics ed. 9 1996 McGraw-Hill New York 399 430
3. L.Z. Benet D.L. Kroetz L.B. Sheiner Pharmacokinetics: The dynamics of drug absorption, distribution, and elimination Hardman J.G. Limbird L.E. Goldman and Gilman's: The Pharmacological Basis of Therapeutics ed9 1996 McGraw-Hill New York 3 27
4. I. Bernus R.G. Dickinson W.D. Hooper Anticonvulsant therapy in aged patients: Clinical pharmacokinetic considerations Drugs Aging 10 1997 278 289
5. R.J. Cadieux Drug interactions in the elderly. How multiple drug use increases risk exponentially Postgrad Med 86 1989 179 186
6. C.M. Castleden C.F. George D. Marcer Increased sensitivity to nitrazepam in old age BMJ 1 1977 10 12
7. D.J. Chapron Influence of advanced age on drug disposition and response Delafuente J.C. Stewart R.B. Therapeutics in the Elderly ed 1 1988 Williams and Wilkins Baltimore 107 120
8. D.S. Chutka J.M. Evans K.C. Fleming Symposium on geriatrics—Part I: Drug prescribing for elderly patients [see comments] Mayo Clin Proc 70 1995 685 693
9. H. Creasey S.I. Rapoport The aging human brain Ann Neurol 17 1985 2 10
10. R.P. Irwin J.G. Nutt Principles of neuropharmacology: I. Pharmacokinetics and pharmacodynamics Klawans H.L. Goetz C.G. Tanner C.M. Textbook of Clinical Neuropharmacology and Therapeutics ed 2 1992 Raven New York 1 14
11. M.V. Johnston F.S. Silverstein Fundamentals of drug therapy in neurology Johnston M.V. Macdonald R.L. Young A.B. Principles of Drug Therapy in Neurology 1992 FA Davis Philadelphia 1 49
12. R.F. Kaiko S.L. Wallenstein A.G. Rogers Narcotics in the elderly Med Clin North Am 66 1982 1079 1089
13. B.G. Katzung Special aspects of geriatric pharmacology Katzung B.G. Basic and Clinical Pharmacology ed 5 1992 Appleton and Lange Norwalk, CT 862 870
14. M. Lader Quality of treatment: What do new antidepressants offer? Int Clin Psychopharmacol 10 1995 5 9
15. A.E. Lang W.J. Weiner Drug-Induced Movement Disorders 1992 Futura Mount Kisco, NY
16. L. Nolan K. O'Malley Prescribing for the elderly. Part I: Sensitivity of the elderly to adverse drug reactions J Am Geriatr Soc 36 1988 142 149
17. J.G. Nutt R.P. Irwin Principles of neuropharmacology: II. Synaptic transmission Klawans H.L. Goetz C.G. Tanner C.M. Textbook of Clinical Neuropharmacology and Therapeutics ed 2 1992 Raven New York 15 22
18. E.J. Pappert Neuroleptic-induced movement disorders: Acute and subacute syndromes Vinken P.J. Bruyn G.W. Intoxication of the Nervous System, Part II 1994 Elsevier Science Amsterdam 273 310
19. J.B. Penney A.B. Young Movement disorders Johnston M.V. Mcdonald R.L. Young A.B. Principles of Drug Therapy in Neurology 1992 FA Davis Philadelphia 50 86
20. G.S. Roth Changes in tissue responsiveness to hormones and neurotransmitters during aging Exp Gerontol 30 1995 361 368
21. C. Salzman Geriatric psychopharmacology Ann Rev Med 36 1985 217 228
22. C. Salzman Key concepts in geriatric psychopharmacology: Altered pharmacokinetics and polypharmacy Psychiatr Clin North Am 5 1982 181 190
23. C. Salzman Neuropsychopharmacology Katzman R. Rowe J.W. Principles of Geriatric Neurology 1992 FA Davis Philadelphia 59 72
24. C. Salzman Pharmacokinetics of psychotropic drugs and the aging process Clinical Geriatric Psychopharmacology 1984 McGraw-Hill New York 32 45
25. J.A. Severson Neurotransmitter receptors and aging J Am Geriatr Soc 32 1984 24 27
26. J.M. Smith R.J. Baldessarini Changes in prevalence, severity, and recovery in tardive dyskinesia with age Arch Gen Psychiatry 37 1980 1368 1373
27. N. Spira M.W. Dysken L.W. Lazarus Treatment of agitation and psychosis Salzman C. Clinical Geriatric Psychopharmacology 1984 McGraw-Hill New York 49 76
28. B.E. Stein Avoiding drug reactions: Seven steps to writing safe prescriptions Geriatrics 49 1994 28 30 33–36
29. A.K. Swonger P.M. Burbank Drug Therapy and the Elderly 1995 Jones and Bartlett Boston
30. W.H. Theodore Clinical pharmacology of antiepileptic drugs: Selected topics Neurol Clin 8 1990 177 191
31. K. Woodhouse H.A. Wynne Age-related changes in hepatic function: Implications for drug therapy Drugs Aging 2 1992 243 255
32. H.A. Wynne L.H. Cope E. Mutch The effect of age upon liver volume and apparent liver blood flow in healthy man Hepatology 9 1989 297 301